Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: Novadaq Technologies Inc. (NVDQ) Report Updated: Sep 24, 2017 | Print This Page

Get more stock ratings by Louis Navellier

Novadaq Technologies Inc. (NVDQ)

Rating: Hold Volatility: Aggressive
Total Grade: C Industry: Health Care Equipment & Supplies

Stock Analysis

Rating: Monthly View

September October November December January February March April May June July August

Rating: Weekly View

This Week: C down upgrade
Last Week: N same downgrade
Two Weeks Ago: B up upgrade
service keys

Novadaq Technologies Inc.© quotemedia

Company Profile

Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products for use by surgeons in the operating room and other clinical settings in the United States and internationally. Its proprietary imaging platform is used to visualize blood vessels, nerves, and the lymphatic system during surgical procedures. The company offers SPY Elite imaging system for use in coronary artery bypass, cardiovascular, plastic, reconstructive, micro, organ transplant, and gastrointestinal surgeries; and PINPOINT endoscopic fluorescence imaging system used for traditional endoscope and to obtain fluorescence images on demand or in a simultaneous imaging mode during minimally invasive surgery. It also provides Firefly imaging systems for use in robotic surgery; LUNA fluorescence angiography that enables clinicians to visually assess tissue perfusion in various cardiovascular procedures; CO2 heart laser system for transmyocardial revascularization; and DermACELL tissue products for use in breast reconstruction surgeries, as well as in the treatment of chronic non-healing wounds. In addition, the company markets SPY Analysis Toolkit, a post-processing software that allows physicians to enhance and apply objective analysis tools to SPY Elite and LUNA images. Novadaq Technologies Inc. was founded in 2000 and is headquartered in Mississauga, Canada.